Redmond Asset Management’s TransCode Therapeutics RNAZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Hold
0
-$100K 176
2022
Q3
Hold
0
-$115K 166
2022
Q2
Hold
0
-$262K 179
2022
Q1
Hold
0
-$224K 174
2021
Q4
Hold
0
186